Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 106

1.

Effectiveness of oral propranolol in a patient with neurofibromatosis type 1 and infantile hemangiomas.

Miraglia E, Schiavetti A, Varrasso G, Celli M, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Mar 29. doi: 10.23736/S0392-0488.19.06179-0. [Epub ahead of print] No abstract available.

PMID:
30924624
2.

A characteristic type of retinal microvascular abnormalities in a patient with Neurofibromatosis type 1.

Moramarco A, Lambiase A, Mallone F, Miraglia E, Giustini S.

Clin Ter. 2019 Jan-Feb;170(1):e4-e9. doi: 10.7417/CT.2019.2101.

3.

Retinal microvascular abnormalities in neurofibromatosis type 1.

Moramarco A, Miraglia E, Mallone F, Roberti V, Iacovino C, Bruscolini A, Giustolisi R, Giustini S.

Br J Ophthalmol. 2019 Jan 31. pii: bjophthalmol-2018-313002. doi: 10.1136/bjophthalmol-2018-313002. [Epub ahead of print]

PMID:
30705042
4.

Melanoma in neurofibromatosis type 1: an Italian single center experience.

Miraglia E, Lopez T, Iacovino C, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Feb;154(1):89-91. doi: 10.23736/S0392-0488.17.05612-7. No abstract available.

PMID:
30616334
5.

Lipomas in Neurofibromatosis Type 1: a single-institution experience.

Miraglia E, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Oct 22. doi: 10.23736/S0392-0488.18.06044-3. [Epub ahead of print] No abstract available.

PMID:
30350556
6.

Two rare disease in the same patient: neurofibromatosis type 1 and Madelung's disease.

Miraglia E, Fino P, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Oct 3. doi: 10.23736/S0392-0488.18.06166-7. [Epub ahead of print] No abstract available.

PMID:
30295449
7.

Nevus spilus in neurofibromatosis type 1: a single center experience.

Miraglia E, Fino P, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Oct 3. doi: 10.23736/S0392-0488.18.06088-1. [Epub ahead of print] No abstract available.

PMID:
30295445
8.

Giant plexiform neurofibroma in neurofibromatosis type 1.

Miraglia E, Lopez T, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Oct;153(5):740-741. doi: 10.23736/S0392-0488.17.05678-4. No abstract available.

PMID:
30246960
9.

Correction: The PH domain from the Toxoplasma gondii PH-containing protein-1 (TgPH1) serves as an ectopic reporter of phosphatidylinositol 3-phosphate in mammalian cells.

Chintaluri K, Goulden BD, Clemenza C, Saffi G, Miraglia E, Hammond GRV, Botelho RJ.

PLoS One. 2018 Jul 31;13(7):e0201800. doi: 10.1371/journal.pone.0201800. eCollection 2018.

10.

Pseudoxanthoma elasticum in Italy: epidemiological and clinical aspects.

Miraglia E, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Jun 29. doi: 10.23736/S0392-0488.18.06076-5. [Epub ahead of print] No abstract available.

PMID:
29963809
11.

Lipomatosis of the caregiver: a new form of cutaneous lipomatosis.

Miraglia E, Fino P, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Jun 29. doi: 10.23736/S0392-0488.18.06055-8. [Epub ahead of print] No abstract available.

PMID:
29963805
12.

The PH domain from the Toxoplasma gondii PH-containing protein-1 (TgPH1) serves as an ectopic reporter of phosphatidylinositol 3-phosphate in mammalian cells.

Chintaluri K, Goulden BD, Clemenza C, Saffi G, Miraglia E, Hammond GRV, Botelho RJ.

PLoS One. 2018 Jun 5;13(6):e0198454. doi: 10.1371/journal.pone.0198454. eCollection 2018. Erratum in: PLoS One. 2018 Jul 31;13(7):e0201800.

13.

SD-OCT in NIR modality to diagnose retinal microvascular abnormalities in neurofibromatosis type 1.

Moramarco A, Giustini S, Miraglia E, Sacchetti M.

Graefes Arch Clin Exp Ophthalmol. 2018 Sep;256(9):1789-1790. doi: 10.1007/s00417-018-4028-3. Epub 2018 Jun 2. No abstract available.

PMID:
29860546
14.

Poliosis circumscripta in association with neurofibromatosis type 1: only a coincidence?

Miraglia E, Roberti V, Lopez T, Iacovino C, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 May 16. doi: 10.23736/S0392-0488.18.05882-0. [Epub ahead of print] No abstract available.

PMID:
29781260
15.

Two sisters with neurofibromatosis type 1 and celiac disease.

Lopez T, Miraglia E, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Jun;153(3):444-446. doi: 10.23736/S0392-0488.17.05576-6. No abstract available.

PMID:
29766709
16.

Effectiveness of oral propranolol for infantile hemangiomas started after 5 months of age.

Lopez T, Miraglia E, Schiavetti A, Varrasso G, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 May 10. doi: 10.23736/S0392-0488.18.05958-8. [Epub ahead of print] No abstract available.

PMID:
29747482
17.

Multiple lipomas in a patient with Neurofibromatosis Type 1.

Miraglia E, Fino P, Lopez T, Iacovino C, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Apr 19. doi: 10.23736/S0392-0488.18.05869-8. [Epub ahead of print] No abstract available.

PMID:
29683278
18.

Juvenile myelomonocytic leukemia in a patient with neurofibromatosis type 1 and xanthogranulomas.

Miraglia E, Fino P, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2018 Mar 29. doi: 10.23736/S0392-0488.18.05983-7. [Epub ahead of print] No abstract available.

PMID:
29600694
19.

A new distal phenotype of Madelung's disease.

Miraglia E, Fino P, Iacovino C, Lopez T, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Jun;154(3):371-372. doi: 10.23736/S0392-0488.18.05760-7. Epub 2018 Jan 24. No abstract available.

PMID:
29368851
20.

Shagreen-patch in a NF1 patient with a new missense mutation.

Lopez T, Paolino G, Miraglia E, Iacovino C, De Luca A, Donati P, Calvieri S, Giustini S.

G Ital Dermatol Venereol. 2019 Apr;154(2):223-224. doi: 10.23736/S0392-0488.18.05724-3. Epub 2018 Jan 24. No abstract available.

PMID:
29368848

Supplemental Content

Loading ...
Support Center